Why the study?
Does normalized VWF multimer quantitation improve the assessment of cardiac lesion severity and bleeding risk in patients with structural heart disease or LVADs?
Does normalized VWF multimer quantitation improve the assessment of cardiac lesion severity and bleeding risk in patients with structural heart disease or LVADs?
Normalized VWF multimer ratios provide a standardized method that strongly correlates with severe cardiac lesions and may aid in risk stratification for bleeding.
Answers are grounded in this paper and cite their sources.
May support bleeding risk stratification in structural heart disease; leaves open prospective validation before clinical adoption.
Unlabelled Box •VWF multimers have an established association with valvular heart disease. •Significant interlaboratory variation exists in VWF multimeric analysis. •We describe a method to normalize VWF multimers for assessment of cardiac lesion severity and clinical bleeding. •Normalized VWF multimer ratios improved the diagnostic capabilities of the assay. Background von Willebrand factor (VWF) multimer quantitation has been utilized in the assessment of valvular heart disease, however, there is no standardized method for quantitation. We compared three methods of assessment which utilized a normal plasma control. Methods We analyzed 476 samples and their control plasma from 368 patients with valvular heart disease, hypertrophic cardiomyopathy, or LVAD therapy, and 27 normal subjects. VWF multimers were assessed as normalized VWF multimer ratios (NMR) of gel bands >15/2‐15 (NMR15) or gel bands >10/2‐10 (NMR10). Associations of VWF laboratory and multimeric assessments with cardiac lesion severity and acquired bleeding were investigated. Results Abnormal multimers were present in 78% of patients with moderate to severe hemodynamic abnormalities compared to 19% of patients with normal or mildly abnormal hemodynamics. NMR showed strong association with severe cardiac lesions (NMR15: OR 15.29, CI 9.04‐27.18; NMR10: OR 14.18, CI 8.88‐23.21). PFA‐CADP was strongly associated with moderate to severe cardiac lesions (OR 14.91, CI 9.08‐24.50). PFA‐CADP and NMR15 showed excellent ability to discriminate ≥moderate (AUC 0.86, CI 0.83‐0.89 and 0.83, CI 0.79‐0.87 respectively) and severe cardiac lesions (AUC 0.84, CI 0.81‐0.88 and 0.85, CI 0.81‐0.88 respectively). NMR was less strongly associated with bleeding (OR 4.01 for NMR10, CI 2.49‐6.58). Conclusion Quantification of VWF multimers may provide clinical utility in circumstances where clinical estimation of cardiac lesion severity is challenging, such as with dysfunctional prosthetic valves. The presence of abnormal VWF multimers is associated with bleeding, however further quantitation provided only modest improvement in risk stratification.
No takes yet. Share an insight, caveat, or question.
Austin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: